• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home StudyGraphics

#VisualAbstract: Immune dysfunction is associated with a higher risk of breakthrough COVID-19 infection

byMinjee Kim
January 5, 2022
in StudyGraphics
Reading Time: 4 mins read
0
Share on FacebookShare on Twitter

1. This retrospective cohort study found that patients with immune dysfunction experienced a reduction in COVID-19 infection incidence after full vaccination.

2. The incidence rate of infection after full vaccination in individuals with immune dysfunction was substantially higher compared to that in individuals without immune dysfunction.

Evidence Rating Level: 2 (Good)

Study Rundown: Breakthrough infection is defined as an infection that occurs after vaccination against a certain pathogen. It has been theorized that immune dysfunction may increase the risk of developing severe outcomes after COVID-19 infection, however conclusions cannot be drawn because these patients have largely been excluded from vaccination trials. One proposed mechanism for this is that individuals with immune deficiency mount a suboptimal immune response to the SARS-CoV-2 vaccine, thus making them more susceptible to the virus. This study investigates the incidence rate (IR) and adjusted IR ratio (AIRR) of breakthrough COVID-19 infection in persons with, compared to without, immune dysfunction. COVID IR and severity, measured by proxy as hospitalization, was taken from the National COVID Cohort Collaborative (N3C) Data Enclave up to September 16, 2021 for those with and without immune dysfunction. Patients with immune dysfunction included human immunodeficiency virus (HIV) patients, those receiving solid organ transplant (SOT), patients with autoimmune diseases like multiple sclerosis (MS) and rheumatoid arthritis (RA), and cancer patients receiving bone marrow transplantation (BMT). Of the 664,722 individuals in the database, 5.3% had immune dysfunction. 90% of the sample received a full set of doses of mRNA vaccines. The sample represented 4,436,139 person-months where 5.0 breakthrough infections occurred per 1000 person-months and the average breakthrough occurred 138 days after full vaccination. There was a greater IR of breakthrough infections in those with, compared to without, immune dysfunction that was independently associated with HIV, RA, and SOT. HIV, SOT, and BMT patients experienced breakthrough infections earlier than non-immune dysfunctional patients. Vaccination reduced COVID hospitalizations in patients without immune dysfunction but increased them in patients with immune dysfunction. This study had several limitations. There was a potential for misclassification as the electronic medical record database may be inaccurate for vaccination at non-hospital sites that do not use the record like pharmacies. Additionally, this bias could be differential because immune-compromised patients may be more likely to go to hospitals for vaccination than non-immune dysfunctional patients. There is a significant confounding variable present in this retrospective cohort study as immunosuppressed patients likely have fewer contacts than those with functional immunity, thus conclusions can only be drawn about IR and not about likelihood of infection.

Click to read the study in JAMA Internal Medicine

RELATED REPORTS

Second-line TAF-based ART improves viral suppression in pediatric HIV

Worsening kidney function observed following SARS-CoV-2 infection in children

The Scan by 2 Minute Medicine®: Climate-Driven Crises, Serena’s Mental Fitness Revolution, Superhuman Immunity, and Healthcare on Strike

Click to read an accompanying editorial in JAMA Internal Medicine

Relevant Reading: Managing Disease-Modifying Therapies and Breakthrough Activity in Multiple Sclerosis Patients During the COVID-19 Pandemic: Toward an Optimized Approach

In-Depth [retrospective cohort]: Self-reported demographic characteristics, pre-existing comorbidities, vaccination status, COVID diagnosis and hospitalization from at least single vaccinated individuals were collected from the N3C database. This study compared the rates of COVID infection and severity between pre- and post-vaccinated patients with and without immune dysfunction. 90% of the sample (N = 664,722 = 4,436,139 person-months) received a full set of doses of an mRNA vaccine. Those with SOT, BMT, or RA groups were older than those without immune dysfunction. Participants with HIV or SOT were more frequently non-Hispanic Black. Those with immune dysfunction had more comorbid health conditions. 5.0 breakthrough infections occurred per 1000 person-months. Fully vaccinated persons experienced a 28% lower risk of breakthrough infection compared to partially vaccinated individuals (AIRR = 0.72, 95% CI = 0.68-0.76). The rate of breakthrough infections was greater in the time after the Delta variant emerged as the dominant strain than the period before (before: IR = 2.2 vs after: IR = 7.3 per 1000 person-months; AIRR = 3.46; 95% CI = 3.23-3.72). Breakthrough infections were associated with older age, being female, and having a greater number of comorbidities. Individuals without immune dysfunction had a lower rate of breakthrough infections than those with immune dysfunction (IR = 7.1, 95% CI = 7.1-7.2 vs HIV: IR = 9.1, 95% CI = 8.8-9.4 per 1000 person-months, MS: IR = 8.9, 95% CI = 8.4-9.3, RA: IR = 9.3, 95% CI = 9.1-9., SOT: IR = 15.7, 95% CI = 15.1-16.4, BMT: IR = 8.6, 95% CI = 8.0-9.1 per 1000 person-months), especially of the Delta variant. Breakthrough infection was associated with each of HIV infection (AIRR = 1.33, 95% CI = 1.18-1.49), RA (AIRR = 1.20, 95% CI = 1.09-1.32), and SOT (AIRR = 2.16, 95% CI = 1.96-2.38). Infection with COVID-19 before vaccination reduced the risk of future infection after vaccination by 56% compared to no pre-vaccination infection (AIRR = 0.44, 95% CI = 0.40-0.48). In this sample, the average time to breakthrough infection was 138 days, with 2.8% of vaccinated patients contracting COVID within 6 months. Patients with immune dysfunction, particularly HIV, SOT, or BMT had a shorter time to breakthrough infection and a greater proportion of breakthrough infection than those without immune dysfunction; for example, 6% of vaccinated SOT patients contracting COVID within 6 months. There were fewer COVID hospitalizations after vaccination than before in patients without immune dysfunction (16.0% vs 24.4%), while there were more COVID hospitalizations after vaccination in those with immune dysfunction (6.3% vs 3.3%), but a decline in severity of those cases.

©2021 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: #COVID vaccination#COVID-19 vaccinationbreakthrough infectionsCOVID breakthrough infectionCOVID-19COVID-19 breakthrough infectionsHIVimmune dysfunctionimmunosuppressionrheumatoid arthritisSARS-CoV-2solid organ transplanttransplant
Previous Post

No significant association between maternal hormonal contraception use and central nervous system tumors in children

Next Post

#VisualAbstract: Taxane monotherapy may be more effective for patients with recurrent or metastatic head and neck cancer and prior nivolumab exposure

RelatedReports

Government-funded initiatives provide important supports to low-income HIV patients
Infectious Disease

Second-line TAF-based ART improves viral suppression in pediatric HIV

June 4, 2025
Being overweight and obese associated with increased incidence of chronic kidney disease
Chronic Disease

Worsening kidney function observed following SARS-CoV-2 infection in children

May 23, 2025
The Scan by 2 Minute Medicine®:  Ultra-Trail du Mont-Blanc, Taylor Swift, NBA rookie Chet Holmgren and Magic Mushrooms!
Chronic Disease

The Scan by 2 Minute Medicine®: Climate-Driven Crises, Serena’s Mental Fitness Revolution, Superhuman Immunity, and Healthcare on Strike

May 7, 2025
Few high school students, young adults get HIV testing
Chronic Disease

Alcohol use disorder may be associated with human immunodeficiency virus

May 3, 2025
Next Post
#VisualAbstract: Hereditary retinoblastoma survivors are at an increased risk for melanoma and non-melanoma skin cancers

#VisualAbstract: Taxane monotherapy may be more effective for patients with recurrent or metastatic head and neck cancer and prior nivolumab exposure

Low evidence for glycerin use in preterm infants

Arterial hyperoxia associated with mortality in critically ill children admitted to the pediatric intensive care unit

Quick Take: Functional Outcome of Intravenous Thrombolysis in Patients With Lacunar Infarcts in the WAKE-UP Trial

Risk of subsequent stroke following Transient Ischemic Attack varies based on receipt of follow-up care

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Intravaginal conjugated oestrogen does not improve continuation rate of ring pessary use
  • Artificial intelligence based clinical decision systems are safe and effective for diabetes management
  • Epic Launchpad propels generative-AI into everyday hospital routines
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.